Executive Summary
The digest covers $237.7 million in total obligations across two civilian agency contracts, with zero defense-related awards. The dominant theme is stable, long-duration federal IT and health data infrastructure, led by Leidos’ $127 million cost-plus contract with the FAA for the Enterprise Information Display System through 2034, signaling recurring revenue but capped margin upside.
Harvard Pilgrim Health Care’s $110.7 million firm-fixed-price FDA Sentinel Initiative contract reinforces demand for health data analytics, though its nonprofit status limits direct equity benefit. The highest-conviction signal is Leidos’ competitive win in full-and-open competition, reinforcing its moat in FAA IT systems. Key risks include the mature phase of Leidos’ base contract (92% outlayed) and Harvard Pilgrim’s contract expiration in December 2024, creating re-compete uncertainty.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal IT & Cybersecurity Contracts digest from August 21, 2026.
Investment Signals (3)
- Leidos Secures $127M FAA IT Win, Reinforcing Long-Term Services Backlog (HIGH)▲
Leidos won a $127 million base cost-plus-fixed-fee contract for the FAA's Enterprise Information Display System, with options extending to $297.6 million through 2034. The full-and-open competition win signals competitive strength in federal IT infrastructure, contributing to Leidos' long-duration services backlog.
- Harvard Pilgrim's $110.7M FDA Contract Nears Expiration, Re-Compete Risk Looms (MEDIUM)▲
Harvard Pilgrim Health Care's $110.7 million firm-fixed-price contract for the FDA Sentinel Initiative Operations Center has $83 million outlayed (75% complete) and expires December 2024. The full-and-open competition nature means the re-compete is vulnerable to new entrants, and the nonprofit status limits direct equity upside for investors.
- Leidos FAA Contract Mature Phase Limits Near-Term Upside (HIGH)▲
Of the $127 million base contract, $122 million has already been outlayed (96% drawn), indicating the base period is nearly complete. Future value depends entirely on option exercises, which are not guaranteed and may face budget scrutiny under a continuing resolution.
Risk Flags (3)
- Execution [MEDIUM RISK]▼
Leidos' $127M FAA contract is cost-plus-fixed-fee, which caps profit margins and limits upside surprises. The mature phase (92% outlayed) means near-term revenue is largely recognized, with future growth dependent on option exercises.
- Competition [HIGH RISK]▼
Harvard Pilgrim's $110.7M FDA contract expires December 2024 and was won via full-and-open competition. The re-compete could attract larger for-profit health IT players (e.g., IQVIA, UnitedHealth Group's Optum), threatening Harvard Pilgrim's position.
- Budget [MEDIUM RISK]▼
Both contracts are civilian (DOT/FAA and HHS/FDA), making them vulnerable to discretionary budget cuts or continuing resolution impacts, especially if Congress fails to pass full-year appropriations for FY2025.
Opportunities (2)
- ◆
Leidos' $127M FAA E-IDS contract has options that could expand total value to $297.6 million through 2034. If exercised, this would represent 134% growth from the base, providing long-duration revenue visibility.
- ◆
The FDA's Sentinel Initiative contract ($110.7M) demonstrates sustained government investment in drug safety surveillance and health data analytics. This could signal follow-on opportunities for health IT contractors (e.g., IQVIA, Booz Allen Hamilton) in FDA-related data infrastructure.
Sector Themes (2)
- ◆
Both contracts (Leidos at FAA, Harvard Pilgrim at FDA) involve critical IT infrastructure modernization—air traffic display systems and health data analytics platforms. The $237.7 million aggregate signals sustained civilian agency demand for IT upgrades, even amid budget uncertainty.
- ◆
Leidos' cost-plus contract ($127M) minimizes profit volatility but caps upside, while Harvard Pilgrim's firm-fixed-price contract ($110.7M) transfers cost risk to the contractor. Investors should favor cost-plus for stability in uncertain budget environments and fixed-price for margin expansion potential.
Watch List (3)
- 👁
{"entity" => "Leidos, Inc.", "reason" => "FAA E-IDS contract base is 92% outlayed; option exercises critical for long-term revenue growth.", "trigger" => "FAA announcement of option exercise for E-IDS contract extensions"}
- 👁
{"entity" => "Harvard Pilgrim Health Care, Inc.", "reason" => "FDA Sentinel contract expires December 2024; re-compete outcome determines future revenue stream.", "trigger" => "FDA pre-solicitation notice or award announcement for Sentinel Initiative Operations Center re-compete"}
- 👁
{"entity" => "Federal IT Sector (ETF: PPA, XAR)", "reason" => "Both contracts are civilian; any FY2025 budget cuts or CRs affecting DOT/HHS could pressure sector valuations.", "trigger" => "Congressional budget resolution or CR passage impacting civilian agency discretionary spending"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal IT & Cybersecurity Contracts
🇺🇸 More from United States
View all →August 26, 2026
US Pre-Market SEC Filings Roundup — August 26, 2026
US Pre-Market SEC Filings Roundup
August 26, 2026
Nasdaq 100 Stocks SEC Filings — August 26, 2026
Nasdaq 100 Stocks SEC Filings
August 26, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 26, 2026
US Activist Hedge Fund Institutional SEC 13D 13G
August 26, 2026
US Material Events SEC 8-K Filings — August 26, 2026
US Material Events SEC 8-K Filings